Biomarkers and clinical trial design

被引:2
作者
Farley, John
Bast, Robert C., Jr.
Birrer, Michael J.
机构
[1] NCI, Ctr Canc Res, Cell & Canc Biol Dept, Bethesda, MD 20892 USA
[2] Uniformed Serv Univ Hlth Sci, Dept Obstet & Gynecol, Bethesda, MD 20814 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA
关键词
gynecologic; malignancies; biologic therapy;
D O I
10.1016/j.ygyno.2006.08.017
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Topics: Relevant biomarkers for the stratification of patients with ovarian cancer, prognostic markers, predictive markers, surrogate markers, tissue banking needs, core laboratories for multi-institutional trials, future trial design Phase II and Phase III.
引用
收藏
页码:S3 / S5
页数:3
相关论文
共 6 条
[1]
Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers [J].
Berchuck, A ;
Iversen, ES ;
Lancaster, JM ;
Pittman, J ;
Luo, JQ ;
Lee, P ;
Murphy, S ;
Dressman, HK ;
Febbo, PG ;
West, M ;
Nevins, JR ;
Marks, JR .
CLINICAL CANCER RESEARCH, 2005, 11 (10) :3686-3696
[2]
Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers [J].
Jazaeri, AA ;
Avvtrey, CS ;
Chandramouli, GVR ;
Chuang, YE ;
Khan, J ;
Sotiriou, C ;
Aprelikova, O ;
Yee, CJ ;
Zorn, KK ;
Birrer, MJ ;
Barrett, JC ;
Boyd, J .
CLINICAL CANCER RESEARCH, 2005, 11 (17) :6300-6310
[3]
Schwartz DR, 2002, CANCER RES, V62, P4722
[4]
Unique gene expression profile based on pathologic response in epithelial ovarian cancer [J].
Spentzos, D ;
Levine, DA ;
Kolia, S ;
Otu, H ;
Boyd, J ;
Libermann, TA ;
Cannistra, SA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) :7911-7918
[5]
Zorn KK, 2003, CLIN CANCER RES, V9, P4811
[6]
Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer [J].
Zorn, KK ;
Bonome, T ;
Gangi, L ;
Chandramouli, GVR ;
Awtrey, CS ;
Gardner, GJ ;
Barrett, JC ;
Boyd, J ;
Birrer, MJ .
CLINICAL CANCER RESEARCH, 2005, 11 (18) :6422-6430